A carregar...
Immunotherapy for head and neck squamous cell carcinoma
Over the past years immuno-oncology has evolved and become a novel promising strategy for cancer therapy. Immune checkpoint inhibitors such as pembrolizumab or nivolumab, which target the interaction between programmed death receptor 1/programmed death ligand 1 (PD-1/PDL-1) and PDL-2, have been rece...
Na minha lista:
| Publicado no: | Memo |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Vienna
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4923082/ https://ncbi.nlm.nih.gov/pubmed/27429658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-016-0270-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|